SLE and pregnancy: The potential role for regulatory T cells

Nature Reviews Rheumatology

Volumn 7, Issue 2, 2011, Pages 124-128

  Tower, Clare ^a   Crocker, Ian ^a   Chirico, Debora ^a   Baker, Philip ^a   Bruce, Ian ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR BETA1;

CD4+ CD25+ T LYMPHOCYTE; DRUG SAFETY; FETUS WASTAGE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INTRAUTERINE GROWTH RETARDATION; LYMPHOCYTE FUNCTION; MORBIDITY; NONHUMAN; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 79651468770     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.124     Document Type: Review

References (35)

1. Dachenko, N., Satia, J. A. & Anthony, M. S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15, 308-318 (2006). (Pubitemid 43828810)
2. Clowse, M. E., Jamison, M., Myers, E. & James, A. H. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol. 199, 127.e1-127.e6 (2008).
3. Yacobi, S., Ornoy, A., Blumenfeld, Z. & Miller, R. K. Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 66, 300-308 (2002). (Pubitemid 36020168)
4. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003). (Pubitemid 36222930)
5. Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic selftolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004). (Pubitemid 38680433)
6. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (ipEX) is caused by mutations of FOXp3. Nat. Genet. 27, 20-21 (2001). (Pubitemid 32044513)
7. Wu, H. Y. & Staines, N. A. A deficiency of CD4+CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 13, 192-200 (2004). (Pubitemid 38478647)
8. Barath, S. et al. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25highFoxp3+ regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40, 521-528 (2007). (Pubitemid 351233173)
9. Bonelli, M. et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20, 861-868 (2008). (Pubitemid 351876312)
10. valencia, X., Yarboro, C., illei, G. & Lipsky, p. E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178, 2579-2588 (2007). (Pubitemid 46233461)
11. Suárez, A., López, p., Gómez, J. & Gutierréz, C. Enrichment of CD4+CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann. Rheum. Dis. 65, 1512-1517 (2006). (Pubitemid 44629132)
12. Yan, B. et al. Dysfunctional CD4+CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 58, 801-812 (2008). (Pubitemid 351364878)
13. Lee, H. Y. et al. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 47, 789-794 (2008).
14. vargas-Rojas, M. i., Crispin, J. C., Richaudpatin, Y. & Alcocer-varela, J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17, 289-294 (2008). (Pubitemid 351655795)
15. Zhang, B. et al. Clinical significance of increased CD4+CD25-FOXp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann. Rheum. Dis. 67, 1037-1040 (2008). (Pubitemid 351956671)
16. Cepika, A. M., Marinic, i., Morovic-vergles, J., Soldo-Juresa, D. & Gagro, A. Effect of steroids on the frequency of regulatory T cells and expression of FOXp3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 16, 374-377 (2007). (Pubitemid 47074842)
17. Zhang, B., Zhang, X., Tang, F., Zhu, L. & Liu, Y. Reduction of forkhead box p3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153, 182-187 (2008). (Pubitemid 351989160)
18. Chirico, D., Bruce, i., Baker, p. & Tower, C. predictors of pregnancy complications in women with systemic lupus erythematosus [abstract]. BJOG 116, 1407-1408 (2009).
19. Horwitz, D. A., Zheng, S. G. & Gray, J. D. Natural and TGF-beta-induced Foxp3+CD4+CD25+ regulatory T cells are not mirror images of each other. Trends Immunol. 29, 429-435 (2008).
20. Marie, J. C., Letterio, J. J., Gavin, M. & Rudensky, A. Y. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 1061-1067 (2005). (Pubitemid 40524674)
21. Dang, H. et al. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol. 155, 3205-3212 (1995).
22. Ohtsuka, K., Gray, J. D., Stimmler, M. M., Toro, B. & Horwitz, D. A. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 160, 2539-2545 (1998). (Pubitemid 28119941)
23. Ohtsuka, K., Gray, J. D., Stimmler, M. M. & Horwitz, D. A. The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8, 90-94 (1999). (Pubitemid 29103593)
24. Jackson, M., Ahmad, Y., Bruce, i. N., Coupes, B. & Brenchley, p. E. Activation of transforming growth factor-β1 and early atherosclerosis in systemic lupus erythematosus. Arthritis Res. Ther. 8, R81 (2006).
25. Blaauw, J. et al. increased intima-media thickness after early-onset pre-eclampsia. Obstet. Gynecol. 107, 1345-1351 (2006). (Pubitemid 44336901)
26. Aluvihare, v. R., Kallikourdis, M. & Betz, A. G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271 (2004). (Pubitemid 38332123)
27. Somerset, D. A., Zheng, Y., Kilby, M. D., Sansom, D. M. & Drayson, M. T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology 112, 38-43 (2004). (Pubitemid 38609820)
28. Tilburgs, T. et al. Differential distribution of CD4+CD25bright and CD8+CD28-T-cells in decidua and maternal blood during human pregnancy. Placenta 27 (Suppl. A), S47-S53 (2006).
29. Sasaki, Y. et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 10, 347-353 (2004). (Pubitemid 38714366)
30. Sasaki, Y. et al. proportion of peripheral blood and decidual CD4+CD25bright regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 149, 139-145 (2007). (Pubitemid 46897107)
31. Darmochwal-Kolarz, D. et al. Activated T lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 58, 39-45 (2007). (Pubitemid 46939026)
32. Clausen, T. et al. Altered plasma concentrations of leptin, transforming growth factor-β1 and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 23, 380-385 (2002). (Pubitemid 41110501)
33. Clark, D. A., Fernandes, J. & Banwatt, D. prevention of spontaneous abortion in the CBA × DBA/2 mouse model by intravaginal TGF-β and local recruitment of CD4+8+FOXp3+ cells. Am. J. Reprod. Immunol. 59, 525-534 (2008). (Pubitemid 351696295)
34. Scarpellini, F. & Sbracia, M. Effectiveness of GM-CSF 1 in the treatment of habitual abortion in a controlled study [abstract 6.7]. Am. J. Reprod. Immunol. 51, 433-434 (2004).
35. Scarpellini, F. & Sbracia, M. G-CSF treatment in unexplained recurrent spontaneous abortion mobilized different lymphocytes and dendritic cells in peripheral blood [abstract 1171570850]. Am. J. Reprod. Immunol. 57, 327 (2007).